Acceptability and Predictors of Uptake of Anti-retroviral Pre-exposure Prophylaxis (PrEP) Among Fishing Communities in Uganda: A Cross-Sectional Discrete Choice Experiment Survey.
Adult
Anti-HIV Agents
/ administration & dosage
Anti-Retroviral Agents
/ administration & dosage
Choice Behavior
Condoms
/ statistics & numerical data
Cross-Sectional Studies
Female
Fisheries
HIV Infections
/ drug therapy
Humans
Male
Patient Acceptance of Health Care
/ psychology
Patient Preference
/ ethnology
Pre-Exposure Prophylaxis
/ methods
Sexually Transmitted Diseases
/ prevention & control
Surveys and Questionnaires
Uganda
/ epidemiology
Discrete choice experiment
Fisherfolk
HIV prevention
Pre-exposure prophylaxis
Uganda
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Oct 2019
Oct 2019
Historique:
pubmed:
9
2
2019
medline:
7
11
2019
entrez:
9
2
2019
Statut:
ppublish
Résumé
We used a discrete choice experiment to assess the acceptability and potential uptake of HIV pre-exposure prophylaxis (PrEP) among 713 HIV-negative members of fishing communities in Uganda. Participants were asked to choose between oral pill, injection, implant, condoms, vaginal ring (women), and men circumcision. Product attributes were HIV prevention effectiveness, sexually transmitted infection (STI) prevention, contraception, waiting time, and secrecy of use. Data were analysed using mixed multinomial logit and latent class models. HIV prevention effectiveness was viewed as the most important attribute. Both genders preferred oral PrEP. Women least preferred the vaginal ring and men the implant. Condom use was predicted to decrease by one third among men, and not to change amongst women. Oral PrEP and other new prevention technologies are acceptable among fishing communities and may have substantial demand. Future work should explore utility of multiple product technologies that combine contraception with HIV and other STI prevention.
Identifiants
pubmed: 30734882
doi: 10.1007/s10461-019-02418-7
pii: 10.1007/s10461-019-02418-7
doi:
Substances chimiques
Anti-HIV Agents
0
Anti-Retroviral Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2674-2686Subventions
Organisme : Center for AIDS Research, University of Washington
ID : PA AI027757